Related Experiment Videos
DNA adduct burden and tobacco carcinogenesis
1Laboratory for Molecular Epidemiology, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, CA 94143-0560, USA. wiencke@itsa.ucsf.edu
Oncogene
|October 16, 2002
Summary
DNA adducts from tobacco smoking can mark carcinogen exposure and predict cancer risk. Research links higher adduct levels to lung, head and neck, and bladder cancers, but more study is needed on dose-response and gene interactions.
Area of Science:
- Biomarkers of Exposure and Disease
- Molecular Epidemiology
- Cancer Research
Background:
- DNA adducts are indicators of biologically effective dose from tobacco carcinogens.
- Elevated DNA adduct levels are linked to major tobacco-related cancers like lung, head and neck, and bladder.
- In vitro DNA adduct inducibility in lymphocytes is a potential risk factor for lung and head and neck cancers.
Purpose of the Study:
- To explore DNA adducts as markers for tobacco carcinogen exposure and cancer risk prediction.
- To investigate the complex relationship between gene polymorphisms, DNA adducts, and tobacco-related cancer risk.
- To identify emerging research avenues integrating DNA adduct analysis with other factors to understand interindividual variability in response to tobacco carcinogens.
Main Methods:
- Review of clinical and epidemiologic studies on DNA adducts and tobacco-related cancers.
- Analysis of in vitro and in vivo studies examining DNA adduct induction by tobacco smoke.
- Examination of molecular studies on tumor genetics, DNA adducts, and carcinogen metabolism/repair gene polymorphisms.
Main Results:
- Consistent associations found between tobacco smoke exposure, DNA adducts, and cancer risk in target tissues.
- Complex and sometimes inconsistent relationships observed between gene polymorphisms (e.g., GSTP1, XRCC1) and DNA adduct levels.
- Molecular tumor studies suggest links between DNA adducts, p53 mutations, and early-stage carcinogenic events (e.g., 3p21 LOH).
Conclusions:
- DNA adducts are valuable biomarkers for tobacco carcinogen exposure and cancer risk assessment.
- Further research is crucial to clarify dose-response relationships and the impact of genetic variations on DNA adduct formation and cancer susceptibility.
- Future research should integrate DNA adduct analysis with genetic, dietary, and environmental factors to unravel the multifactorial nature of tobacco carcinogenesis.